CMND
Clearmind Medicine Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.16
−31.76%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-68.8%
Return on equity
-54.4%
Return on assets
-69.9%
Return on invested capital
0.00x
Asset turnover
-$6.8M
Cash from operations
$9.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Apr 1, 2026